Loading insider details...
Beta
Latest Form 4 (Aug 24, 2026): Gift of 50,000 REPL shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 24, 2026 | Replimune Group, Inc. (REPL) | Gift | 50,000 | n/a |
| Jun 17, 2026 | enGene Therapeutics Inc. (ENGN) | Grant/Award | 31,000 | n/a |
| May 20, 2026 | Replimune Group, Inc. (REPL) | Sale | 17,657 | $89.7K |
| Apr 8, 2026 | Replimune Group, Inc. (REPL) | Grant/Award | 50,000 | n/a |
| Feb 20, 2026 | Replimune Group, Inc. (REPL) | Gift | 25,000 | n/a |
| Jul 10, 2025 | enGene Holdings Inc. (ENGN) | Grant/Award | 45,000 | n/a |
| May 23, 2025 | Replimune Group, Inc. (REPL) | Sale | 32,279 | $260.2K |
| Aug 31, 2024 | Replimune Group, Inc. (REPL) | Gift | 50,000 | n/a |
| May 21, 2024 | Replimune Group, Inc. (REPL) | Sale | 37,928 | $245.4K |
| May 19, 2023 | Replimune Group, Inc. (REPL) | Sale | 17,902 | $323.1K |